Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OralvacB2MPL
- Development stage
- Phase 1
- Lead developer
- Allergy Therapeutics
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Sublingual
01
Overview
OralvacB2MPL appears to be a sublingual immunotherapy (SLIT) product, likely used for the treatment of allergies. While there is no direct information about "OralvacB2MPL" in the provided search results, similar products such as "Oralvac Compact" are described as drops administered under the tongue to treat severe allergies when standard medications are insufficient. These types of therapies typically contain allergen extracts and work by gradually desensitizing the immune system to specific allergens through repeated exposure. The mechanism involves modulation of immune responses, including changes in antibody production and T-cell activity, ultimately reducing allergic symptoms[1]. The developer or manufacturer is not specified in available sources.
- Brand names
- OralvacB2MPLOralvacB-2MPLOralvacB 2MPL
- Other names
- OralvacB2MPLOralvacB-2MPLOralvacB 2MPL
02
Targets
Bet v 2TCR (T cell antigen receptor complex)IgE (Immunoglobulin E)
Beyond the preview
Go deeper on OralvacB2MPL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OralvacB2MPL.